Business Wire

NV-BELKIN

8.1.2024 02:01:33 CET | Business Wire | Press release

Share
Belkin supercharges into CES 2024 with powerful new product lineup

Belkin, a leading consumer electronics brand for 40 years, today introduced four new products across its mobile power and connectivity portfolios, underscoring Belkin innovation, design excellence, dedication to quality, and commitment to building products more responsibly. Belkin is showcasing its newly announced products at CES Unveiled Las Vegas – the official media event of CES 2024.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240107725407/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Belkin supercharges into CES 2024 with powerful new product lineup (Photo: Business Wire)

Charging in a snap with Qi2

BoostCharge Pro ​3-in-1 Magnetic Stand

Leveraging the new Qi2 standard, this powerful 3-in-1 wireless charger offers perfect alignment and reliable charging for Qi2-enabled devices at 15W, fast charging for Apple Watch Series 7 and later, and optimal charging for wireless earbuds. Built to include an adjustable hinge, users can effortlessly adjust the angle of the phone for optimal viewing while watching videos, reading articles or video chatting. It is made with a minimum 75% post-consumer recycled (PCR) materials.

$149.99 USD

Coming March 2024 to select markets worldwide

BoostCharge Pro Magnetic Power Bank

The Qi2 magnetic power bank delivers up to 15W of power for Qi2-enabled devices on-the-go, without the hassle of cables. It is engineered with an integrated kickstand for propping the phone up while streaming, reading, or chatting, and works with magnetic and MagSafe cases up to 3mm thick. “Power pass-through” allows for charging the power bank and Qi2 device in one simple action via USB-C port. Offered in 5K, 8K and 10K options, consumers can choose the best power bank for their charging needs. Internal housing (excluding cable) of this product is made with a minimum 72% PCR materials.

$59.99, $79.99, $99.99 USD

Coming March 2024 to select markets worldwide

Power-packed and compact with GaN

BoostCharge Pro 4-Port USB-C GaN Charger 200W

The new 4-Port USB-C GaN Wall Charger packs an impressive 200W of power for fast charging up to 4 devices at the same time. It supports high powered laptops and gaming laptops and is engineered with GaN technology and Programmable Power Supply (PPS) to provide efficient power output and smart power allocation, giving connected devices a safe and optimal charge. The 4-Port USB-C GaN Wall Charger declutters the workspace while charging laptops, tablets, phones, smart watches and earbuds simultaneously – no extra power bricks needed. It is compact and power-packed, measured at 92mm x 118.5mm x 35.5mm, and 650g/1.32lbs. The housing (excluding power cord) of this product is made with a minimum 72% PCR materials.

$129.99 USD

Coming March 2024 to belkin.com and select markets worldwide

6-in-1 Core GaN Dock

Belkin is innovating its docks category with the use of GaN to deliver smaller, more efficient, more responsible workspace solutions. Approximately 50 percent smaller1 than other 6-in-1 solutions and highly spec'd to support all essential needs, the Core GaN Dock features 1x HDMI port for high-definition display resolutions up to 4K, 2x USB-A ports for legacy devices, 2x USB-C ports (1 with 96W power delivery), and 1 gigabit ethernet port for secure and reliable Internet connection.

$139.99 USD

Available to order now on belkin.com

Coming soon to select retailers worldwide

Built more responsibly

In line with the company’s commitment to find more responsible ways to build products, Belkin’s newly announced BoostCharge solutions are made with a minimum of 72% PCR materials and sold in plastic-free packaging. One year since Belkin announced its transition to PCR, it has transitioned over 200 products to incorporate PCR, and has replaced 64 metric tons of virgin plastic with PCR materials. Belkin remains committed to its goal of 100% carbon neutrality in its offices and operations (scope 1 & 2 emissions) by 2025 while tackling product level emissions (scope 3).

Media kit is available for download HERE.

About Belkin

Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From the humble beginnings of a garage in 1980s Southern California to a diverse, global technology company today, we remain forever inspired by the planet we live on, and the connection between people and technology.

1 Based on internal tests against competing non-GaN solutions with power supply unit. Dimensions: 80 x 80 x 48mm; surface area: 6,400mm

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240107725407/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye